Colson Medical, LLC is pleased to announce the merger of two Colson Medical companies, Acumed and OsteoMed. Operations will be integrated gradually over the coming year while maintaining both global brands.
“Individually, these two great companies are longtime leaders in providing innovative, practical products for orthopedic surgeries,” said Chris Smith, Colson Medical President. “Together, they will bring even greater value to the worldwide medical community.”
The combined business will focus on these key surgical markets:
• Hand/Upper Extremity
• Foot/Ankle
• Trauma (including chest wall injury)
• Craniomaxillofacial (CMF) and Neurosurgery (Neuro)
• Tendon/Ligament Repair and Biologics
“We are uniting the strengths of Acumed and OsteoMed to enhance the experience of our customers and their patients,” said Acumed CEO Sharon Wolfington, who will lead the combined business.
“We will continue to offer a growing product portfolio for both the Acumed and OsteoMed brands, leverage investments in systems and processes, and create business continuity with manufacturing and inventory in multiple locations,” Wolfington added. “As always, our goal is to deliver comprehensive solutions to assist our customers in achieving optimal patient outcomes and restoration of function.”
About Colson Medical
Chicago-based Colson Medical, LLC designs and manufactures specialty medical devices worldwide through its five businesses: Acumed, OsteoMed, MicroAire, Precision Edge, and Apex. These businesses offer innovative products used to help improve patient care and outcomes. They provide highly engineered implants such as plates, screws, and related precision tools, primarily for upper and lower extremity orthopedic, CMF, Neuro, and aesthetics surgeries. Together, they employ more than 1,300 people at locations in the U.S., China, the U.K., Spain, and Germany. Marmon Holdings, Inc., a Berkshire Hathaway company, acquired a majority interest in the Colson Medical Companies in 2019.
